Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/90007
Title: Long-term culture of human liver tissue with advanced hepatic functions
Authors: Xiong, Anming
Ng, Soon Seng
Nguyen, Khanh
Masek, Marilyn
No, Da Yoon
Elazar, Menashe
Shteyer, Eyal
Winters, Mark A.
Voedisch, Amy
Shaw, Kate
Rashid, Sheikh Tamir
Frank, Curtis W.
Cho, Nam Joon
Glenn, Jeffrey S.
Keywords: DRNTU::Engineering::Materials
Technical Advance
Gastroenterology
Issue Date: 2017
Source: Ng, S. S., Xiong, A., Nguyen, K., Masek, M., No, D. Y., Elazar, M., Shteyer, E., et al. (2017). Long-term culture of human liver tissue with advanced hepatic functions. JCI Insight, 2(11), e90853-. doi:10.1172/jci.insight.90853
Series/Report no.: JCI Insight
Abstract: A major challenge for studying authentic liver cell function and cell replacement therapies is that primary human hepatocytes rapidly lose their advanced function in conventional, 2-dimensional culture platforms. Here, we describe the fabrication of 3-dimensional hexagonally arrayed lobular human liver tissues inspired by the liver’s natural architecture. The engineered liver tissues exhibit key features of advanced differentiation, such as human-specific cytochrome P450–mediated drug metabolism and the ability to support efficient infection with patient-derived inoculums of hepatitis C virus. The tissues permit the assessment of antiviral agents and maintain their advanced functions for over 5 months in culture. This extended functionality enabled the prediction of a fatal human-specific hepatotoxicity caused by fialuridine (FIAU), which had escaped detection by preclinical models and short-term clinical studies. The results obtained with the engineered human liver tissue in this study provide proof-of-concept determination of human-specific drug metabolism, demonstrate the ability to support infection with human hepatitis virus derived from an infected patient and subsequent antiviral drug testing against said infection, and facilitate detection of human-specific drug hepatotoxicity associated with late-onset liver failure. Looking forward, the scalability and biocompatibility of the scaffold are also ideal for future cell replacement therapeutic strategies.
URI: https://hdl.handle.net/10356/90007
http://hdl.handle.net/10220/47177
DOI: 10.1172/jci.insight.90853
Rights: © 2017 American Society for Clinical Investigation (ASCI). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/bync/4.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:MSE Journal Articles

Files in This Item:
File Description SizeFormat 
Long-term culture of human liver tissue with advanced hepatic functions.pdf2.03 MBAdobe PDFThumbnail
View/Open

SCOPUSTM   
Citations 20

7
Updated on Jul 13, 2020

PublonsTM
Citations 20

7
Updated on Mar 4, 2021

Page view(s)

85
Updated on Jun 11, 2021

Download(s) 50

31
Updated on Jun 11, 2021

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.